Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart

Hiroaki Masuzaki, Hisato Jingami, Naoki Matsuoka, Osamu Nakagawa, Yoshihiro Ogawa, Megumi Mizuno, Yasunao Yoshimasa, Tokuo Yamamoto, Kazuwa Nakao

研究成果: ジャーナルへの寄稿記事

32 引用 (Scopus)

抄録

To elucidate the regulation of very-low-density lipoprotein (VLDL) receptor, we have studied its gene expression in the heart of spontaneously hypertensive rat-stroke prone (SHR-SP, an animal model for hypertension- induced cardiac hypertrophy) compared with Wistar-Kyoto rats. RNase protection assay showed that ventricular VLDL receptor mRNA falls to 41% of normal levels at 4 weeks, when hypertensions is not yet fully developed, and drops further to 14% at 13 weeks, when cardiac hypertrophy is established. Lipoprotein lipase mRNA decreases in parallel with VLDL receptor mRNA. In cultured neonatal rat ventricular cardiomyocytes. VLDL receptor mRNA decreases in parallel with the process of cardiocyte hypertrophy during the 24 hours after treatment with 10-8 mol/L endothelin-1, falling to 40% of the initial value. These results demonstrate that there is downregulation of VLDL receptor gene expression in cardiac hypertrophy both in vivo and in vitro and suggest that the regulation of the VLDL receptor is possibly linked with the switch in energy substrate from lipid to glucose known to occur in cardiac hypertrophy.

元の言語英語
ページ(範囲)8-14
ページ数7
ジャーナルCirculation Research
78
発行部数1
DOI
出版物ステータス出版済み - 1 1 1996
外部発表Yes

Fingerprint

Cardiomegaly
Messenger RNA
Hypertension
Gene Expression
Inbred WKY Rats
Lipoprotein Lipase
Endothelin-1
Inbred SHR Rats
Ribonucleases
Cardiac Myocytes
Hypertrophy
VLDL receptor
Down-Regulation
Animal Models
Stroke
Lipids
Glucose

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

これを引用

Masuzaki, H., Jingami, H., Matsuoka, N., Nakagawa, O., Ogawa, Y., Mizuno, M., ... Nakao, K. (1996). Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circulation Research, 78(1), 8-14. https://doi.org/10.1161/01.RES.78.1.8

Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. / Masuzaki, Hiroaki; Jingami, Hisato; Matsuoka, Naoki; Nakagawa, Osamu; Ogawa, Yoshihiro; Mizuno, Megumi; Yoshimasa, Yasunao; Yamamoto, Tokuo; Nakao, Kazuwa.

:: Circulation Research, 巻 78, 番号 1, 01.01.1996, p. 8-14.

研究成果: ジャーナルへの寄稿記事

Masuzaki, H, Jingami, H, Matsuoka, N, Nakagawa, O, Ogawa, Y, Mizuno, M, Yoshimasa, Y, Yamamoto, T & Nakao, K 1996, 'Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart', Circulation Research, 巻. 78, 番号 1, pp. 8-14. https://doi.org/10.1161/01.RES.78.1.8
Masuzaki, Hiroaki ; Jingami, Hisato ; Matsuoka, Naoki ; Nakagawa, Osamu ; Ogawa, Yoshihiro ; Mizuno, Megumi ; Yoshimasa, Yasunao ; Yamamoto, Tokuo ; Nakao, Kazuwa. / Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. :: Circulation Research. 1996 ; 巻 78, 番号 1. pp. 8-14.
@article{8c07b61cd267458d811158f072b816f0,
title = "Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart",
abstract = "To elucidate the regulation of very-low-density lipoprotein (VLDL) receptor, we have studied its gene expression in the heart of spontaneously hypertensive rat-stroke prone (SHR-SP, an animal model for hypertension- induced cardiac hypertrophy) compared with Wistar-Kyoto rats. RNase protection assay showed that ventricular VLDL receptor mRNA falls to 41{\%} of normal levels at 4 weeks, when hypertensions is not yet fully developed, and drops further to 14{\%} at 13 weeks, when cardiac hypertrophy is established. Lipoprotein lipase mRNA decreases in parallel with VLDL receptor mRNA. In cultured neonatal rat ventricular cardiomyocytes. VLDL receptor mRNA decreases in parallel with the process of cardiocyte hypertrophy during the 24 hours after treatment with 10-8 mol/L endothelin-1, falling to 40{\%} of the initial value. These results demonstrate that there is downregulation of VLDL receptor gene expression in cardiac hypertrophy both in vivo and in vitro and suggest that the regulation of the VLDL receptor is possibly linked with the switch in energy substrate from lipid to glucose known to occur in cardiac hypertrophy.",
author = "Hiroaki Masuzaki and Hisato Jingami and Naoki Matsuoka and Osamu Nakagawa and Yoshihiro Ogawa and Megumi Mizuno and Yasunao Yoshimasa and Tokuo Yamamoto and Kazuwa Nakao",
year = "1996",
month = "1",
day = "1",
doi = "10.1161/01.RES.78.1.8",
language = "English",
volume = "78",
pages = "8--14",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart

AU - Masuzaki, Hiroaki

AU - Jingami, Hisato

AU - Matsuoka, Naoki

AU - Nakagawa, Osamu

AU - Ogawa, Yoshihiro

AU - Mizuno, Megumi

AU - Yoshimasa, Yasunao

AU - Yamamoto, Tokuo

AU - Nakao, Kazuwa

PY - 1996/1/1

Y1 - 1996/1/1

N2 - To elucidate the regulation of very-low-density lipoprotein (VLDL) receptor, we have studied its gene expression in the heart of spontaneously hypertensive rat-stroke prone (SHR-SP, an animal model for hypertension- induced cardiac hypertrophy) compared with Wistar-Kyoto rats. RNase protection assay showed that ventricular VLDL receptor mRNA falls to 41% of normal levels at 4 weeks, when hypertensions is not yet fully developed, and drops further to 14% at 13 weeks, when cardiac hypertrophy is established. Lipoprotein lipase mRNA decreases in parallel with VLDL receptor mRNA. In cultured neonatal rat ventricular cardiomyocytes. VLDL receptor mRNA decreases in parallel with the process of cardiocyte hypertrophy during the 24 hours after treatment with 10-8 mol/L endothelin-1, falling to 40% of the initial value. These results demonstrate that there is downregulation of VLDL receptor gene expression in cardiac hypertrophy both in vivo and in vitro and suggest that the regulation of the VLDL receptor is possibly linked with the switch in energy substrate from lipid to glucose known to occur in cardiac hypertrophy.

AB - To elucidate the regulation of very-low-density lipoprotein (VLDL) receptor, we have studied its gene expression in the heart of spontaneously hypertensive rat-stroke prone (SHR-SP, an animal model for hypertension- induced cardiac hypertrophy) compared with Wistar-Kyoto rats. RNase protection assay showed that ventricular VLDL receptor mRNA falls to 41% of normal levels at 4 weeks, when hypertensions is not yet fully developed, and drops further to 14% at 13 weeks, when cardiac hypertrophy is established. Lipoprotein lipase mRNA decreases in parallel with VLDL receptor mRNA. In cultured neonatal rat ventricular cardiomyocytes. VLDL receptor mRNA decreases in parallel with the process of cardiocyte hypertrophy during the 24 hours after treatment with 10-8 mol/L endothelin-1, falling to 40% of the initial value. These results demonstrate that there is downregulation of VLDL receptor gene expression in cardiac hypertrophy both in vivo and in vitro and suggest that the regulation of the VLDL receptor is possibly linked with the switch in energy substrate from lipid to glucose known to occur in cardiac hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=0030060017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030060017&partnerID=8YFLogxK

U2 - 10.1161/01.RES.78.1.8

DO - 10.1161/01.RES.78.1.8

M3 - Article

C2 - 8603509

AN - SCOPUS:0030060017

VL - 78

SP - 8

EP - 14

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -